Back
Nuvalent Vs. Replimune Group Industry Stock Comparison
Sell
45
NUVL
Nuvalent
Last Price:
96.65
Seasonality Move:
7.57%
Buy
54
REPL
Replimune Group
Last Price:
14.13
Seasonality Move:
-14.22%
Sell
45
Nuvalent (NUVL)
is a Sell
Is Nuvalent a Buy, Sell or Hold?
- The current Nuvalent [NUVL] share price is $96.68. The Score for NUVL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Replimune Group (REPL)
is a Buy
Is Replimune Group a Buy, Sell or Hold?
- The current Replimune Group [REPL] share price is $14.08. The Score for REPL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- REPL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REPL Stock Price Chart
What is Replimune Group's stock price today?
-
The Replimune Group share price today is $14.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.
NUVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 57.65 | Buy |
Chaikin Money Flow: | 103927 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.31 - 94.93) | Buy |
Bollinger Bands (100): | (78.53 - 100.13) | Buy |
REPL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.57 | Buy |
Relative Strength Index (14 RSI): | 61.34 | Buy |
Chaikin Money Flow: | -325352 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.17 - 13.35) | Buy |
Bollinger Bands (100): | (9.92 - 12.12) | Buy |
NUVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.41 | Buy |
20-day SMA: | 92.5 | Buy |
50-day SMA: | 97.05 | Sell |
200-day SMA: | 82.03 | Buy |
8-day EMA: | 94.77 | Buy |
20-day EMA: | 93.79 | Buy |
50-day EMA: | 93.46 | Buy |
200-day EMA: | 82.55 | Buy |
REPL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.99 | Buy |
20-day SMA: | 12.33 | Buy |
50-day SMA: | 11.83 | Buy |
200-day SMA: | 9.25 | Buy |
8-day EMA: | 13.3 | Buy |
20-day EMA: | 12.56 | Buy |
50-day EMA: | 11.85 | Buy |
200-day EMA: | 10.74 | Buy |
Nuvalent Earnings Growth & NUVL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.61 per share, and a decrease next year of $0.69 per share.
Replimune Group Earnings Growth & REPL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.
Nuvalent Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Replimune Group Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |